TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
8.61
-0.03 (-0.35%)
At close: Dec 5, 2025, 4:00 PM EST
8.75
+0.14 (1.63%)
After-hours: Dec 5, 2025, 4:10 PM EST

TransCode Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Net Income
-27.13-16.75-18.55-17.56-6.84-2.34
Upgrade
Depreciation & Amortization
0.190.530.520.10.04-
Upgrade
Loss (Gain) From Sale of Assets
----0-
Upgrade
Stock-Based Compensation
0.591.71.040.40.190.05
Upgrade
Other Operating Activities
11.211.54--0.911.5
Upgrade
Change in Accounts Payable
0.84-0.34-1.31.842.290.19
Upgrade
Change in Unearned Revenue
--00.03-0.030.03-
Upgrade
Change in Other Net Operating Assets
-0.22-0.010.19-0.5-1.880.12
Upgrade
Operating Cash Flow
-14.52-13.34-18.07-15.76-5.27-0.49
Upgrade
Capital Expenditures
-0-0.02-0.04-0.1-0.25-
Upgrade
Sale of Property, Plant & Equipment
----0-
Upgrade
Investing Cash Flow
-0-0.02-0.04-0.1-0.25-
Upgrade
Long-Term Debt Issued
-----1.19
Upgrade
Net Debt Issued (Repaid)
-----1.19
Upgrade
Issuance of Common Stock
15.9416.415.910.0126.38-
Upgrade
Other Financing Activities
-0.46----0.86-0.07
Upgrade
Financing Cash Flow
15.4816.415.910.0125.521.12
Upgrade
Net Cash Flow
0.963.04-2.2-15.86200.62
Upgrade
Free Cash Flow
-14.52-13.36-18.11-15.86-5.52-0.49
Upgrade
Free Cash Flow Per Share
-31.10-1050.30----
Upgrade
Cash Interest Paid
0.010.020.030.040.02-
Upgrade
Levered Free Cash Flow
-9.22-7.53-11.21-9.96-3.7-0.31
Upgrade
Unlevered Free Cash Flow
-9.21-7.51-11.17-9.94-3.64-0.07
Upgrade
Change in Working Capital
0.62-0.35-1.081.310.430.31
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.